rs3747517

Variant summary

Our verdict is Benign. Variant got -18 ACMG points: 2P and 20B. PM1BP4_StrongBP6_Very_StrongBA1

The NM_022168.4(IFIH1):​c.2528A>G​(p.His843Arg) variant causes a missense change. The variant allele was found at a frequency of 0.699 in 1,612,150 control chromosomes in the GnomAD database, including 399,290 homozygotes. In-silico tool predicts a benign outcome for this variant. 12/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.68 ( 35508 hom., cov: 31)
Exomes 𝑓: 0.70 ( 363782 hom. )

Consequence

IFIH1
NM_022168.4 missense

Scores

1
17

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:8O:1

Conservation

PhyloP100: 4.75
Variant links:
Genes affected
IFIH1 (HGNC:18873): (interferon induced with helicase C domain 1) IFIH1 encodes MDA5 which is an intracellular sensor of viral RNA that triggers the innate immune response. Sensing RNA length and secondary structure, MDA5 binds dsRNA oligonucleotides with a modified DExD/H-box helicase core and a C-terminal domain, thus leading to a proinflammatory response that includes interferons. It has been shown that Coronaviruses (CoVs) as well as various other virus families, are capable of evading the MDA5-dependent interferon response, thus impeding the activation of the innate immune response to infection. MDA5 has also been shown to play an important role in enhancing natural killer cell function in malaria infection. In addition to its protective role in antiviral responses, MDA5 has been implicated in autoimmune and autoinflammatory diseases such as type 1 diabetes, systemic lupus erythematosus, and Aicardi-Goutieres syndrome[provided by RefSeq, Jul 2020]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -18 ACMG points.

PM1
In a domain Helicase C-terminal (size 182) in uniprot entity IFIH1_HUMAN there are 6 pathogenic changes around while only 2 benign (75%) in NM_022168.4
BP4
Computational evidence support a benign effect (MetaRNN=8.693561E-7).
BP6
Variant 2-162272314-T-C is Benign according to our data. Variant chr2-162272314-T-C is described in ClinVar as [Benign]. Clinvar id is 261565.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AMR) allele frequency at 95% confidence interval = 0.765 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
IFIH1NM_022168.4 linkuse as main transcriptc.2528A>G p.His843Arg missense_variant 13/16 ENST00000649979.2 NP_071451.2
IFIH1XM_047445407.1 linkuse as main transcriptc.1811A>G p.His604Arg missense_variant 12/15 XP_047301363.1

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
IFIH1ENST00000649979.2 linkuse as main transcriptc.2528A>G p.His843Arg missense_variant 13/16 NM_022168.4 ENSP00000497271 P1Q9BYX4-1

Frequencies

GnomAD3 genomes
AF:
0.677
AC:
102798
AN:
151802
Hom.:
35460
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.622
Gnomad AMI
AF:
0.684
Gnomad AMR
AF:
0.776
Gnomad ASJ
AF:
0.688
Gnomad EAS
AF:
0.321
Gnomad SAS
AF:
0.571
Gnomad FIN
AF:
0.633
Gnomad MID
AF:
0.742
Gnomad NFE
AF:
0.728
Gnomad OTH
AF:
0.700
GnomAD3 exomes
AF:
0.678
AC:
169606
AN:
250338
Hom.:
59530
AF XY:
0.673
AC XY:
91061
AN XY:
135292
show subpopulations
Gnomad AFR exome
AF:
0.622
Gnomad AMR exome
AF:
0.819
Gnomad ASJ exome
AF:
0.685
Gnomad EAS exome
AF:
0.308
Gnomad SAS exome
AF:
0.590
Gnomad FIN exome
AF:
0.643
Gnomad NFE exome
AF:
0.731
Gnomad OTH exome
AF:
0.693
GnomAD4 exome
AF:
0.701
AC:
1024283
AN:
1460232
Hom.:
363782
Cov.:
37
AF XY:
0.698
AC XY:
507034
AN XY:
726516
show subpopulations
Gnomad4 AFR exome
AF:
0.610
Gnomad4 AMR exome
AF:
0.813
Gnomad4 ASJ exome
AF:
0.684
Gnomad4 EAS exome
AF:
0.344
Gnomad4 SAS exome
AF:
0.586
Gnomad4 FIN exome
AF:
0.650
Gnomad4 NFE exome
AF:
0.725
Gnomad4 OTH exome
AF:
0.681
GnomAD4 genome
AF:
0.677
AC:
102910
AN:
151918
Hom.:
35508
Cov.:
31
AF XY:
0.671
AC XY:
49846
AN XY:
74250
show subpopulations
Gnomad4 AFR
AF:
0.623
Gnomad4 AMR
AF:
0.776
Gnomad4 ASJ
AF:
0.688
Gnomad4 EAS
AF:
0.321
Gnomad4 SAS
AF:
0.573
Gnomad4 FIN
AF:
0.633
Gnomad4 NFE
AF:
0.728
Gnomad4 OTH
AF:
0.702
Alfa
AF:
0.713
Hom.:
102301
Bravo
AF:
0.687
TwinsUK
AF:
0.721
AC:
2674
ALSPAC
AF:
0.727
AC:
2800
ESP6500AA
AF:
0.624
AC:
2751
ESP6500EA
AF:
0.726
AC:
6244
ExAC
AF:
0.674
AC:
81812
Asia WGS
AF:
0.475
AC:
1653
AN:
3478
EpiCase
AF:
0.730
EpiControl
AF:
0.724

ClinVar

Significance: Benign
Submissions summary: Benign:8Other:1
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2Other:1
not provided, no classification providedphenotyping onlyGenomeConnect, ClinGen-Variant interpreted as Benign and reported on 04-27-2020 by Lab or GTR ID 500031. GenomeConnect assertions are reported exactly as they appear on the patient-provided report from the testing laboratory. GenomeConnect staff make no attempt to reinterpret the clinical significance of the variant. This variant was reported in an individual referred for clinical diagnostic genetic testing. -
Benign, criteria provided, single submitterclinical testingGeneDxMar 18, 2021This variant is associated with the following publications: (PMID: 31866997, 27720759, 17000706, 23535865) -
Benign, criteria provided, single submitternot providedBreakthrough Genomics, Breakthrough Genomics-- -
not specified Benign:2
Benign, criteria provided, single submitterclinical testingUnidad de Genómica Garrahan, Hospital de Pediatría GarrahanNov 12, 2023This variant is classified as Benign based on local population frequency. This variant was detected in 92% of patients studied by a panel of primary immunodeficiencies. Number of patients: 88. Only high quality variants are reported. -
Benign, criteria provided, single submitterclinical testingPreventionGenetics, part of Exact Sciences-- -
Singleton-Merten syndrome 1 Benign:2
Benign, criteria provided, single submitterclinical testingGenome-Nilou LabAug 10, 2021- -
Benign, criteria provided, single submitterclinical testingMendelicsMay 28, 2019- -
Aicardi-Goutieres syndrome 7 Benign:1
Benign, criteria provided, single submitterclinical testingGenome-Nilou LabAug 10, 2021- -
Aicardi-Goutieres syndrome 7;C4225427:Singleton-Merten syndrome 1 Benign:1
Benign, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpFeb 01, 2024- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.035
BayesDel_addAF
Benign
-0.72
T
BayesDel_noAF
Benign
-0.66
CADD
Benign
18
DANN
Benign
0.55
DEOGEN2
Benign
0.070
T;T;.
Eigen
Benign
-0.83
Eigen_PC
Benign
-0.44
FATHMM_MKL
Benign
0.32
N
LIST_S2
Benign
0.35
.;T;T
MetaRNN
Benign
8.7e-7
T;T;T
MetaSVM
Benign
-0.97
T
MutationAssessor
Benign
-2.5
N;N;.
MutationTaster
Benign
1.0
P;P
PrimateAI
Uncertain
0.49
T
PROVEAN
Benign
4.2
.;N;.
REVEL
Benign
0.16
Sift
Benign
1.0
.;T;.
Sift4G
Benign
1.0
.;T;.
Polyphen
0.0
B;B;.
Vest4
0.14
MPC
0.027
ClinPred
0.0039
T
GERP RS
5.8
Varity_R
0.091
gMVP
0.49

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs3747517; hg19: chr2-163128824; COSMIC: COSV55127127; API